Global Influenza Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Influenza Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Influenza Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Influenza Drugs by Country/Region, 2017, 2022 & 2028

2.2 Influenza Drugs Segment by Type

2.2.1 Zanamivir

2.2.2 Oseltamivir Phosphate

2.2.3 Peramivir

2.2.4 Other Influenza Drugs

2.3 Influenza Drugs Sales by Type

2.3.1 Global Influenza Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Influenza Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Influenza Drugs Sale Price by Type (2017-2022)

2.4 Influenza Drugs Segment by Application

2.4.1 Adults

2.4.2 Chidren

2.5 Influenza Drugs Sales by Application

2.5.1 Global Influenza Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Influenza Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Influenza Drugs Sale Price by Application (2017-2022)

3 Global Influenza Drugs by Company

3.1 Global Influenza Drugs Breakdown Data by Company

3.1.1 Global Influenza Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Influenza Drugs Sales Market Share by Company (2020-2022)

3.2 Global Influenza Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Influenza Drugs Revenue by Company (2020-2022)

3.2.2 Global Influenza Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Influenza Drugs Sale Price by Company

3.4 Key Manufacturers Influenza Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Influenza Drugs Product Location Distribution

3.4.2 Players Influenza Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Influenza Drugs by Geographic Region

4.1 World Historic Influenza Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Influenza Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Influenza Drugs Annual Revenue by Geographic Region

4.2 World Historic Influenza Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Influenza Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Influenza Drugs Annual Revenue by Country/Region

4.3 Americas Influenza Drugs Sales Growth

4.4 APAC Influenza Drugs Sales Growth

4.5 Europe Influenza Drugs Sales Growth

4.6 Middle East & Africa Influenza Drugs Sales Growth

5 Americas

5.1 Americas Influenza Drugs Sales by Country

5.1.1 Americas Influenza Drugs Sales by Country (2017-2022)

5.1.2 Americas Influenza Drugs Revenue by Country (2017-2022)

5.2 Americas Influenza Drugs Sales by Type

5.3 Americas Influenza Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Influenza Drugs Sales by Region

6.1.1 APAC Influenza Drugs Sales by Region (2017-2022)

6.1.2 APAC Influenza Drugs Revenue by Region (2017-2022)

6.2 APAC Influenza Drugs Sales by Type

6.3 APAC Influenza Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Influenza Drugs by Country

7.1.1 Europe Influenza Drugs Sales by Country (2017-2022)

7.1.2 Europe Influenza Drugs Revenue by Country (2017-2022)

7.2 Europe Influenza Drugs Sales by Type

7.3 Europe Influenza Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Influenza Drugs by Country

8.1.1 Middle East & Africa Influenza Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Influenza Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Influenza Drugs Sales by Type

8.3 Middle East & Africa Influenza Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Influenza Drugs

10.3 Manufacturing Process Analysis of Influenza Drugs

10.4 Industry Chain Structure of Influenza Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Influenza Drugs Distributors

11.3 Influenza Drugs Customer

12 World Forecast Review for Influenza Drugs by Geographic Region

12.1 Global Influenza Drugs Market Size Forecast by Region

12.1.1 Global Influenza Drugs Forecast by Region (2023-2028)

12.1.2 Global Influenza Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Influenza Drugs Forecast by Type

12.7 Global Influenza Drugs Forecast by Application

13 Key Players Analysis

13.1 Bristol-Myers Squibb]

13.1.1 Bristol-Myers Squibb] Company Information

13.1.2 Bristol-Myers Squibb] Influenza Drugs Product Offered

13.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bristol-Myers Squibb] Main Business Overview

13.1.5 Bristol-Myers Squibb] Latest Developments

13.2 AstraZeneca

13.2.1 AstraZeneca Company Information

13.2.2 AstraZeneca Influenza Drugs Product Offered

13.2.3 AstraZeneca Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Main Business Overview

13.2.5 AstraZeneca Latest Developments

13.3 Eli Lilly

13.3.1 Eli Lilly Company Information

13.3.2 Eli Lilly Influenza Drugs Product Offered

13.3.3 Eli Lilly Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Eli Lilly Main Business Overview

13.3.5 Eli Lilly Latest Developments

13.4 Roche

13.4.1 Roche Company Information

13.4.2 Roche Influenza Drugs Product Offered

13.4.3 Roche Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Roche Main Business Overview

13.4.5 Roche Latest Developments

13.5 GlaxoSmithKline

13.5.1 GlaxoSmithKline Company Information

13.5.2 GlaxoSmithKline Influenza Drugs Product Offered

13.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline Main Business Overview

13.5.5 GlaxoSmithKline Latest Developments

13.6 Novartis

13.6.1 Novartis Company Information

13.6.2 Novartis Influenza Drugs Product Offered

13.6.3 Novartis Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis Main Business Overview

13.6.5 Novartis Latest Developments

13.7 Pfizer

13.7.1 Pfizer Company Information

13.7.2 Pfizer Influenza Drugs Product Offered

13.7.3 Pfizer Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Pfizer Main Business Overview

13.7.5 Pfizer Latest Developments

13.8 Sanofi Pasteur

13.8.1 Sanofi Pasteur Company Information

13.8.2 Sanofi Pasteur Influenza Drugs Product Offered

13.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Pasteur Main Business Overview

13.8.5 Sanofi Pasteur Latest Developments

13.9 Bayer

13.9.1 Bayer Company Information

13.9.2 Bayer Influenza Drugs Product Offered

13.9.3 Bayer Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bayer Main Business Overview

13.9.5 Bayer Latest Developments

13.10 Celgene

13.10.1 Celgene Company Information

13.10.2 Celgene Influenza Drugs Product Offered

13.10.3 Celgene Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Celgene Main Business Overview

13.10.5 Celgene Latest Developments

13.11 Seqirus

13.11.1 Seqirus Company Information

13.11.2 Seqirus Influenza Drugs Product Offered

13.11.3 Seqirus Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Seqirus Main Business Overview

13.11.5 Seqirus Latest Developments

13.12 Protein Sciences Corporation

13.12.1 Protein Sciences Corporation Company Information

13.12.2 Protein Sciences Corporation Influenza Drugs Product Offered

13.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Protein Sciences Corporation Main Business Overview

13.12.5 Protein Sciences Corporation Latest Developments

13.13 Serum Institute of India

13.13.1 Serum Institute of India Company Information

13.13.2 Serum Institute of India Influenza Drugs Product Offered

13.13.3 Serum Institute of India Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Serum Institute of India Main Business Overview

13.13.5 Serum Institute of India Latest Developments

13.14 Emergent Biosolutions

13.14.1 Emergent Biosolutions Company Information

13.14.2 Emergent Biosolutions Influenza Drugs Product Offered

13.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Emergent Biosolutions Main Business Overview

13.14.5 Emergent Biosolutions Latest Developments

13.15 BioCryst Pharmaceuticals

13.15.1 BioCryst Pharmaceuticals Company Information

13.15.2 BioCryst Pharmaceuticals Influenza Drugs Product Offered

13.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 BioCryst Pharmaceuticals Main Business Overview

13.15.5 BioCryst Pharmaceuticals Latest Developments

13.16 Alvogen

13.16.1 Alvogen Company Information

13.16.2 Alvogen Influenza Drugs Product Offered

13.16.3 Alvogen Influenza Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Alvogen Main Business Overview

13.16.5 Alvogen Latest Developments

14 Research Findings and Conclusion

Table 1. Influenza Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Influenza Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Zanamivir

Table 4. Major Players of Oseltamivir Phosphate

Table 5. Major Players of Peramivir

Table 6. Major Players of Other Influenza Drugs

Table 7. Global Influenza Drugs Sales by Type (2017-2022) & (K MT)

Table 8. Global Influenza Drugs Sales Market Share by Type (2017-2022)

Table 9. Global Influenza Drugs Revenue by Type (2017-2022) & ($ million)

Table 10. Global Influenza Drugs Revenue Market Share by Type (2017-2022)

Table 11. Global Influenza Drugs Sale Price by Type (2017-2022) & (USD/MT)

Table 12. Global Influenza Drugs Sales by Application (2017-2022) & (K MT)

Table 13. Global Influenza Drugs Sales Market Share by Application (2017-2022)

Table 14. Global Influenza Drugs Revenue by Application (2017-2022)

Table 15. Global Influenza Drugs Revenue Market Share by Application (2017-2022)

Table 16. Global Influenza Drugs Sale Price by Application (2017-2022) & (USD/MT)

Table 17. Global Influenza Drugs Sales by Company (2020-2022) & (K MT)

Table 18. Global Influenza Drugs Sales Market Share by Company (2020-2022)

Table 19. Global Influenza Drugs Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Influenza Drugs Revenue Market Share by Company (2020-2022)

Table 21. Global Influenza Drugs Sale Price by Company (2020-2022) & (USD/MT)

Table 22. Key Manufacturers Influenza Drugs Producing Area Distribution and Sales Area

Table 23. Players Influenza Drugs Products Offered

Table 24. Influenza Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Influenza Drugs Sales by Geographic Region (2017-2022) & (K MT)

Table 28. Global Influenza Drugs Sales Market Share Geographic Region (2017-2022)

Table 29. Global Influenza Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Influenza Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Influenza Drugs Sales by Country/Region (2017-2022) & (K MT)

Table 32. Global Influenza Drugs Sales Market Share by Country/Region (2017-2022)

Table 33. Global Influenza Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Influenza Drugs Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Influenza Drugs Sales by Country (2017-2022) & (K MT)

Table 36. Americas Influenza Drugs Sales Market Share by Country (2017-2022)

Table 37. Americas Influenza Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Influenza Drugs Revenue Market Share by Country (2017-2022)

Table 39. Americas Influenza Drugs Sales by Type (2017-2022) & (K MT)

Table 40. Americas Influenza Drugs Sales Market Share by Type (2017-2022)

Table 41. Americas Influenza Drugs Sales by Application (2017-2022) & (K MT)

Table 42. Americas Influenza Drugs Sales Market Share by Application (2017-2022)

Table 43. APAC Influenza Drugs Sales by Region (2017-2022) & (K MT)

Table 44. APAC Influenza Drugs Sales Market Share by Region (2017-2022)

Table 45. APAC Influenza Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Influenza Drugs Revenue Market Share by Region (2017-2022)

Table 47. APAC Influenza Drugs Sales by Type (2017-2022) & (K MT)

Table 48. APAC Influenza Drugs Sales Market Share by Type (2017-2022)

Table 49. APAC Influenza Drugs Sales by Application (2017-2022) & (K MT)

Table 50. APAC Influenza Drugs Sales Market Share by Application (2017-2022)

Table 51. Europe Influenza Drugs Sales by Country (2017-2022) & (K MT)

Table 52. Europe Influenza Drugs Sales Market Share by Country (2017-2022)

Table 53. Europe Influenza Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Influenza Drugs Revenue Market Share by Country (2017-2022)

Table 55. Europe Influenza Drugs Sales by Type (2017-2022) & (K MT)

Table 56. Europe Influenza Drugs Sales Market Share by Type (2017-2022)

Table 57. Europe Influenza Drugs Sales by Application (2017-2022) & (K MT)

Table 58. Europe Influenza Drugs Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Influenza Drugs Sales by Country (2017-2022) & (K MT)

Table 60. Middle East & Africa Influenza Drugs Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Influenza Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Influenza Drugs Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Influenza Drugs Sales by Type (2017-2022) & (K MT)

Table 64. Middle East & Africa Influenza Drugs Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Influenza Drugs Sales by Application (2017-2022) & (K MT)

Table 66. Middle East & Africa Influenza Drugs Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Influenza Drugs

Table 68. Key Market Challenges & Risks of Influenza Drugs

Table 69. Key Industry Trends of Influenza Drugs

Table 70. Influenza Drugs Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Influenza Drugs Distributors List

Table 73. Influenza Drugs Customer List

Table 74. Global Influenza Drugs Sales Forecast by Region (2023-2028) & (K MT)

Table 75. Global Influenza Drugs Sales Market Forecast by Region

Table 76. Global Influenza Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Influenza Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Influenza Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 79. Americas Influenza Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Influenza Drugs Sales Forecast by Region (2023-2028) & (K MT)

Table 81. APAC Influenza Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Influenza Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Europe Influenza Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Influenza Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 85. Middle East & Africa Influenza Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Influenza Drugs Sales Forecast by Type (2023-2028) & (K MT)

Table 87. Global Influenza Drugs Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Influenza Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Influenza Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Influenza Drugs Sales Forecast by Application (2023-2028) & (K MT)

Table 91. Global Influenza Drugs Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Influenza Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Influenza Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 94. Bristol-Myers Squibb] Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. Bristol-Myers Squibb] Influenza Drugs Product Offered

Table 96. Bristol-Myers Squibb] Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 97. Bristol-Myers Squibb] Main Business

Table 98. Bristol-Myers Squibb] Latest Developments

Table 99. AstraZeneca Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. AstraZeneca Influenza Drugs Product Offered

Table 101. AstraZeneca Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 102. AstraZeneca Main Business

Table 103. AstraZeneca Latest Developments

Table 104. Eli Lilly Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. Eli Lilly Influenza Drugs Product Offered

Table 106. Eli Lilly Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 107. Eli Lilly Main Business

Table 108. Eli Lilly Latest Developments

Table 109. Roche Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Roche Influenza Drugs Product Offered

Table 111. Roche Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 112. Roche Main Business

Table 113. Roche Latest Developments

Table 114. GlaxoSmithKline Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. GlaxoSmithKline Influenza Drugs Product Offered

Table 116. GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 117. GlaxoSmithKline Main Business

Table 118. GlaxoSmithKline Latest Developments

Table 119. Novartis Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. Novartis Influenza Drugs Product Offered

Table 121. Novartis Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 122. Novartis Main Business

Table 123. Novartis Latest Developments

Table 124. Pfizer Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Pfizer Influenza Drugs Product Offered

Table 126. Pfizer Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 127. Pfizer Main Business

Table 128. Pfizer Latest Developments

Table 129. Sanofi Pasteur Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. Sanofi Pasteur Influenza Drugs Product Offered

Table 131. Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 132. Sanofi Pasteur Main Business

Table 133. Sanofi Pasteur Latest Developments

Table 134. Bayer Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. Bayer Influenza Drugs Product Offered

Table 136. Bayer Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 137. Bayer Main Business

Table 138. Bayer Latest Developments

Table 139. Celgene Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. Celgene Influenza Drugs Product Offered

Table 141. Celgene Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 142. Celgene Main Business

Table 143. Celgene Latest Developments

Table 144. Seqirus Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. Seqirus Influenza Drugs Product Offered

Table 146. Seqirus Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 147. Seqirus Main Business

Table 148. Seqirus Latest Developments

Table 149. Protein Sciences Corporation Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 150. Protein Sciences Corporation Influenza Drugs Product Offered

Table 151. Protein Sciences Corporation Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 152. Protein Sciences Corporation Main Business

Table 153. Protein Sciences Corporation Latest Developments

Table 154. Serum Institute of India Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 155. Serum Institute of India Influenza Drugs Product Offered

Table 156. Serum Institute of India Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 157. Serum Institute of India Main Business

Table 158. Serum Institute of India Latest Developments

Table 159. Emergent Biosolutions Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 160. Emergent Biosolutions Influenza Drugs Product Offered

Table 161. Emergent Biosolutions Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 162. Emergent Biosolutions Main Business

Table 163. Emergent Biosolutions Latest Developments

Table 164. BioCryst Pharmaceuticals Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 165. BioCryst Pharmaceuticals Influenza Drugs Product Offered

Table 166. BioCryst Pharmaceuticals Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 167. BioCryst Pharmaceuticals Main Business

Table 168. BioCryst Pharmaceuticals Latest Developments

Table 169. Alvogen Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors

Table 170. Alvogen Influenza Drugs Product Offered

Table 171. Alvogen Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 172. Alvogen Main Business

Table 173. Alvogen Latest Developments

List of Figures

Figure 1. Picture of Influenza Drugs

Figure 2. Influenza Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Influenza Drugs Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Influenza Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Influenza Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Zanamivir

Figure 10. Product Picture of Oseltamivir Phosphate

Figure 11. Product Picture of Peramivir

Figure 12. Product Picture of Other Influenza Drugs

Figure 13. Global Influenza Drugs Sales Market Share by Type in 2021

Figure 14. Global Influenza Drugs Revenue Market Share by Type (2017-2022)

Figure 15. Influenza Drugs Consumed in Adults

Figure 16. Global Influenza Drugs Market: Adults (2017-2022) & (K MT)

Figure 17. Influenza Drugs Consumed in Chidren

Figure 18. Global Influenza Drugs Market: Chidren (2017-2022) & (K MT)

Figure 19. Global Influenza Drugs Sales Market Share by Application (2017-2022)

Figure 20. Global Influenza Drugs Revenue Market Share by Application in 2021

Figure 21. Influenza Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Influenza Drugs Revenue Market Share by Company in 2021

Figure 23. Global Influenza Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Influenza Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Influenza Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Influenza Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Influenza Drugs Sales 2017-2022 (K MT)

Figure 28. Americas Influenza Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Influenza Drugs Sales 2017-2022 (K MT)

Figure 30. APAC Influenza Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Influenza Drugs Sales 2017-2022 (K MT)

Figure 32. Europe Influenza Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Influenza Drugs Sales 2017-2022 (K MT)

Figure 34. Middle East & Africa Influenza Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Influenza Drugs Sales Market Share by Country in 2021

Figure 36. Americas Influenza Drugs Revenue Market Share by Country in 2021

Figure 37. United States Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Influenza Drugs Sales Market Share by Region in 2021

Figure 42. APAC Influenza Drugs Revenue Market Share by Regions in 2021

Figure 43. China Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Influenza Drugs Sales Market Share by Country in 2021

Figure 50. Europe Influenza Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Influenza Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Influenza Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Influenza Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Influenza Drugs in 2021

Figure 64. Manufacturing Process Analysis of Influenza Drugs

Figure 65. Industry Chain Structure of Influenza Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles